|Biological E.Limited currently has productive partnerships with several well respected and renowned Institutions and Public Health Services across the world. These collaborations are aimed at giving us access to innovative products for the future. It is also in keeping with the Company's overall philosophy of preventing major life-threatening illnesses and making critical preventive healthcare accessible to the common man.
Details of our current partners and collaborators are given below:
Nederlands Vaccine Institute (NVI), Netherlands :NVI is a part of the Ministry of Health, Netherlands and is a premier institute in the world for vaccine development. Biological E Limited has a technical partnership with NVI for Haemophilus Influenzae - B vaccine (Hib).
For details see website http://www.nvi-vaccin.nl/nl/
Intercell AG, Austria : Intercell is a leading research based vaccine institute in Europe. Biological E Limited has a joint development and marketing relationship with Intercell AG with regard to the Japanese Encephalitis (JE) vaccine.
For details see website www.intercell.com
National Institute of Health (NIH), U.S.A. :The NIH is a part of the Public Health Service (PHS) under the Department of Health and Human Services (DHHS), USA . The NIH is a leading research institute, Headquarters in Bethesda, Maryland, USA. Biological E Limited has an agreement with them for the development and production of Dengue and Rota Virus vaccines.
For details see website http://www.nih.gov
Indian Institute of Science (IISc), Bangalore - India :The IISc is a premier institute imparting higher education and research in science. Biological E Limited had obtained the Hepatitis - B technology from the IISc, Bangalore.
For details see website http://www.iisc.ernet.in/
International Centre for Diarrhoeal Disease Research (ICDDR), Bangladesh :The ICDDR is a leading cholera institute supported by the Centre for Health and Population Research at Dhaka. Biological E Limited has a tie up with the ICDDR to develop and manufacture Cholera Vaccine.